Organoid Clinical Trials

13 recruitingLast updated: May 11, 2026

There are 13 actively recruiting organoid clinical trials across 6 countries. Studies span Phase 2, Not Applicable. Top locations include Hangzhou, Zhejiang, China, Roma, Italy, Shanghai, Shanghai Municipality, China. Updated daily from ClinicalTrials.gov.


Organoid Trials at a Glance

13 actively recruiting trials for organoid are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 2 with 2 trials, with the heaviest enrollment activity in Hangzhou, Roma, and Shanghai. Lead sponsors running organoid studies include Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Huashan Hospital, and Second Affiliated Hospital, School of Medicine, Zhejiang University.

Browse organoid trials by phase

Treatments under study

About Organoid Clinical Trials

Looking for clinical trials for Organoid? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Organoid trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Organoid clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting

Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment

Triple-Negative Breast CancerOrganoid
Centre Francois Baclesse163 enrolled1 locationNCT05404321
Recruiting
Not Applicable

Organoid Models of Hepatocellular Carcinoma

SurgeryHepatocellular CarcinomaOrganoids+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS150 enrolled1 locationNCT06929845
Recruiting

PDO Based Drug Sensitive Test in R/M HNSCC

Head and Neck Squamous Cell CarcinomaPatient Derived OrganoidDrug Sensitive Test in Vitro
Huashan Hospital100 enrolled2 locationsNCT06686342
Recruiting

PDO Based Drug Sensitive Test in R/M SGC

Salivary Gland CancersPatient Derived OrganoidDrug Sensitive Test in Vitro
Huashan Hospital40 enrolled2 locationsNCT06686979
Recruiting
Phase 2

Testing a Functional Precision Medicine Approach to Select Chemotherapy for Metastatic Colorectal Cancer (COSENSE-1)

Metastatic Colorectal CancerFirst-line TreatmentOrganoids+3 more
St. Olavs Hospital148 enrolled1 locationNCT06907342
Recruiting

Drug Response Testing and Repurposing Using Glioblastoma Organoid

GlioblastomaOrganoid
Chungnam National University Hospital150 enrolled1 locationNCT06782984
Recruiting

Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer

Breast CancerNeoadjuvant ChemotherapyOrganoids
Second Affiliated Hospital, School of Medicine, Zhejiang University58 enrolled1 locationNCT06155305
Recruiting

Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast Cancer

Breast Cancer MetastaticHydrothoraxAscites+2 more
Second Affiliated Hospital, School of Medicine, Zhejiang University90 enrolled3 locationsNCT06658080
Recruiting

Bern Human Organoid-Study to Study Host-microbe Interaction

OrganoidsMicrobiotaAllergy and Immunology
Insel Gruppe AG, University Hospital Bern100 enrolled1 locationNCT05323357
Recruiting

Observation of Clinical Consistency of Organoid-chips Drug Sensitivity in Chemotherapy for PCa With Visceral Metastasis

Prostate CancerOrganoid
Tianjin Medical University Second Hospital35 enrolled2 locationsNCT06536725
Recruiting

Patient-derived Organoids of Lung Cancer to Test Drug Response

Lung CancerOrganoid
University Hospital, Geneva50 enrolled1 locationNCT03979170
Recruiting
Phase 2

Organoids Predict Therapeutic Response in Patients With Multi-line Drug-resistant Lung Cancer

Lung CancerOrganoid
Affiliated Hospital of Jiangnan University50 enrolled1 locationNCT05669586
Recruiting

Breast Cancer Subtype Characterization Through Patient's Derived Organoids.

Breast CancerOrganoids
Fondazione Policlinico Universitario Agostino Gemelli IRCCS306 enrolled1 locationNCT06315868